M. Riazi Esfahani, Z Aalami, Gholami, AR Tabasi, A Mirshahi, M Movasat Advantages: To introduce the neuroprotective effect of Memantine (an NMDA type glutamatergic open-channel blocker) in visual functions of patients with acute NAION (Nonarteritic anterior ischemic optic neuropathy) and comparing it with placebo. Methods: Eligible eyes were randomly allocated to either Memantine tablets (5mg daily for first week and 10mg daily for the...

Read More